Volpara bid underwhelming but hard to beat: Bell Potter

Volpara bid underwhelming but hard to beat: Bell Potter
Volpara has developed a breast cancer detection system. (Image: NZME)
Pattrick Smellie
The bid by South Korean firm Lunit to take over fast-growing Wellington medical AI provider Volpara Technologies at A$1.15 (NZ$1.124) a share is no more than “good enough”, but is unlikely to be beaten, says Sydney broking house Bell Potter.Pitched at a 47.4% premium to Australian securties exchange-listed (ASX) Volpara’s closing price on Dec 13, the offer values the company, which is on the cusp of profitability after more than seven years as a publicly listed company, at a “mere US$193 million [NZ$311m]”.How...

More Markets

Nvidia earnings boost markets, NZ sharemarket closes up
Markets Market Close

Nvidia earnings boost markets, NZ sharemarket closes up

The S&P/NZX 50 Index closed up 0.84% or 112.502 points. 

Jade Software to acquire Contec Group
Markets

Jade Software to acquire Contec Group

The acquisition adds Contec’s Madcap software to Jade’s portfolio.

AFT forges ahead with China iron injectable deal
Markets

AFT forges ahead with China iron injectable deal

Oldest iron products in Aussie are booming, while new iron injectable gets China boost.

Meridian says hydro is key to energy security and affordability
Markets

Meridian says hydro is key to energy security and affordability

Meridian says it has learnt lessons from winter 2024.